Given the presence of deep deletions in the ATG7 gene [47] and the presence of RPS6KB1-VMP1 gene fusions [48] in subsets of esophageal cancer patients, it may be critical to take into account the impact of patient genetics upon the use of autophagy factors as biomarkers in esophageal cancer. This evidence concerns the gene VMP1 and esophageal cancer.